Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

TAP announces new corporate identity

The Automation Partnership, a leading supplier of innovative automation for life science applications today announced that the company will now be known as TAP Biosystems.

30 Mar 2011

Unilife initiates Unifill syringe production for pharmaceutical companies

Unilife Corporation today announced it has commenced initial production of the Unifill ready-to-fill syringe at its FDA-registered manufacturing facility in York, Pennsylvania.

30 Mar 2011

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2010, and also provided updates on a number of key corporate objectives.

30 Mar 2011

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Lotus Pharmaceuticals, Inc., a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2010.

29 Mar 2011

Cleveland Medical Devices Inc. spins off Great Lakes NeuroTech

Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.

28 Mar 2011

Positron to move PosiRx system to commercial deployment

Positron Corporation is pleased to announce that its PosiRx system has met critical test standards and guidelines necessary to move on to the commercial deployment stage of its development.

28 Mar 2011

A.P. Pharma fourth quarter revenue decreases to $1.6 million

A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its fourth quarter and full year ended December 31, 2010 and provided a corporate update.

28 Mar 2011

German company steps up production of Radiogardase following Japan nuclear crisis

Heyltex Corporation is the exclusive U.S. distributor of Radiogardase® (Prussian Blue insoluble capsules), the only FDA-approved drug to treat people who have been internally contaminated with radioactive cesium (Cs-137), which is manufactured by Heyl chem. pharm. Fabrik Berlin GmbH in Germany.

25 Mar 2011

CPRIT awards Bellicum $5.7 million to advance CaspaCIDe therapy for late stage cancer

Bellicum Pharmaceuticals, Inc. today announced that the Company received notice of a $5.7 million company commercialization award from the Cancer Prevention and Research Institute of Texas ("CPRIT"). Bellicum was the only company recommended for funding in this second round of the commercialization award program.

25 Mar 2011

Teleflex to distribute Perouse line of POLYSITE intravenous implantable infusion ports

Teleflex Incorporated, a global provider of medical technology products, announced a global distribution agreement with Perouse Medical under which Teleflex will distribute the Perouse line of POLYSITE® intravenous implantable infusion ports.

25 Mar 2011

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

25 Mar 2011

P&G, Teva sign partnership agreement for consumer health care

The Procter & Gamble Company and Teva Pharmaceutical Industries Ltd. today announced the signing of a master agreement to create a partnership in consumer health care by bringing together both companies' existing over-the-counter medicines and complementary capabilities to accelerate growth.

25 Mar 2011

Althea extends labeling, packaging of biological product services through Sherpa

Althea Technologies, Inc. announced today that it has extended its service offering to include labeling, packaging, storage and distribution of drug and biological products through its co-marketing partner, Sherpa Clinical Packaging.

25 Mar 2011

Stemedica begins allogeneic mesenchymal stem cell Phase I/II trial in patients with ischemic stroke

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that its specially formulated ischemic adult allogeneic mesenchymal stem cells have been successfully used to treat the first patient in an ischemic stroke study conducted at the University of California, San Diego.

25 Mar 2011

BrainStorm provides review of recent accomplishments for shareholders, investors

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, today provided a review of recent accomplishments for shareholders and investors.

25 Mar 2011

Opinions: Using taxes to reduce poverty; fighting TB; meeting global food demands

To improve living standards and create jobs," African governments "need to provide their citizens with better health care, better education, more infrastructure. How to pay for this - in a way that is both fair and efficient - is a question that all governments face," Mark Plant, deputy director of the IMF's African Department, writes in a BusinessDay opinion piece where he describes how increased tax revenues in several African countries have led to "in-roads into poverty reduction."

25 Mar 2011

Boehringer Ingelheim formally acquires Amgen's Fremont manufacturing site

Today Boehringer Ingelheim formally acquired Amgen's biopharmaceutical development and manufacturing facility in Fremont, California. This acquisition involves leasing buildings, acquiring physical equipment and assuming manufacturing processes done at the Fremont site.

25 Mar 2011

FDA clears MASEP Infini's gamma ray neurosurgery system

MASEP Infini, an innovator in global medical technology, today announced 510(k) clearance from the U.S. Food and Drug Administration of its new Infini gamma ray neurosurgery system with patented Independent Beam Switch Control with Programmable Arcs, automated collimator exchange and three-dimensional patient positioning, and MASEP Infini's proven Rotary Focusing technology.

24 Mar 2011

ACT to be awarded broad patent protection in China for hESC-derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that China's State Intellectual Property Office (SIPO) has allowed the Company's patent application to provide broad intellectual property protection in China for the manufacturing and pharmaceutical preparations of retinal pigment epithelial (RPE) cells from human embryonic stem cells (hESCs).

24 Mar 2011

Ansell announces substantial price increase for NRL medical gloves

Following a continued increase of raw materials costs, Ansell Medical Solutions Europe, the regional branch of the world leader in hand protective solutions for healthcare professionals, has announced substantial price increases for its entire range of NRL medical gloves.

23 Mar 2011

Manufacturing News and Research

Further Reading

TAP announces new corporate identity

Unilife initiates Unifill syringe production for pharmaceutical companies

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

Lotus fiscal year revenue increases 28.7% to $72.7 million for 2010

Cleveland Medical Devices Inc. spins off Great Lakes NeuroTech

Positron to move PosiRx system to commercial deployment

A.P. Pharma fourth quarter revenue decreases to $1.6 million

German company steps up production of Radiogardase following Japan nuclear crisis

CPRIT awards Bellicum $5.7 million to advance CaspaCIDe therapy for late stage cancer

Teleflex to distribute Perouse line of POLYSITE intravenous implantable infusion ports

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

P&G, Teva sign partnership agreement for consumer health care

Althea extends labeling, packaging of biological product services through Sherpa

Stemedica begins allogeneic mesenchymal stem cell Phase I/II trial in patients with ischemic stroke

BrainStorm provides review of recent accomplishments for shareholders, investors

Opinions: Using taxes to reduce poverty; fighting TB; meeting global food demands

Boehringer Ingelheim formally acquires Amgen's Fremont manufacturing site

FDA clears MASEP Infini's gamma ray neurosurgery system

ACT to be awarded broad patent protection in China for hESC-derived RPE cells

Ansell announces substantial price increase for NRL medical gloves

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News